abstract |
FIELD: medicine.SUBSTANCE: invention relates to medicine, in particular to salvianolic acid T described by structural formula (I), or a pharmaceutically acceptable salt thereof, or an R- or S-isomer thereof.structural formula (I).EFFECT: invention relates to the use of a compound of salvianolic acid T or a pharmaceutically acceptable salt thereof or R or S isomer thereof for antioxidant action, for slowing aging or for treating acute myocardial infarction, acute myocardial ischemia, or fibrotic lung disease.25 cl, 22 dwg, 13 tbl, 4 ex |